WST Valuation

West Pharmaceutical Services Inc

Add to Watchlist

Advanced Chart

279.100

+51.79(22.784%)1D

Overview
Forecast
Valuation
Earnings

WST Relative Valuation

WST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, WST is overvalued; if below, it's undervalued.

Historical Valuation

West Pharmaceutical Services Inc (WST) is now in the Fair zone, suggesting that its current forward PE ratio of 34.40 is considered Fairly compared with the five-year average of 44.45. The fair price of West Pharmaceutical Services Inc (WST) is between 220.30 to 310.90 according to relative valuation methord.

Relative Value

Fair Zone

220.30-310.90

Current Price：227.31

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

7.47

P/B

Median3y

8.52

Median5y

10.19

1.88

FCF Yield

Median3y

1.67

Median5y

1.51

Competitors Valuation Multiple

The average P/S ratio for WST's competitors is 3.50, providing a benchmark for relative valuation. West Pharmaceutical Services Inc Corp (WST) exhibits a P/S ratio of 5.41, which is 54.45% above the industry average. Given its robust revenue growth of 9.17%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

WST.N

West Pharmaceutical Services Inc

5.41

Average P/S: 3.50

9.17%